Status:
UNKNOWN
Adrenal Venous Sampling Via an Antecubital Approach
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions:
Hyperaldosteronism
Angiography
Eligibility:
All Genders
18+ years
Brief Summary
Currently, adrenal venous sampling (AVS) serves as the gold standard for subtyping of PA. Right adrenal vein catheterization is often difficult due to unfavorable anatomy of the vein including small v...
Detailed Description
Primary aldosteronism (PA) is recognized as the most common cause of secondary hypertension, with a prevalence of approximately 10% among unselected hypertensive populations. Subtype diagnosis is cruc...
Eligibility Criteria
Inclusion
- Consent of the principal investigator to participate to the data collection of patients with primary aldosteronism underwent AVS via antecubital approach
Exclusion
- Refusal of the principal investigator to participate to the AVSA Study
Key Trial Info
Start Date :
July 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2018
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT03778645
Start Date
July 1 2018
End Date
December 31 2018
Last Update
December 21 2018
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, China, 100037
2
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
3
The Eighth Affiliated Hospital of Sun Yat-sen University
Shenzhen, Guangdong, China
4
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China